
COVID-19: impact on biotech clinical research in Spain 2020
More than 57 percent of the biotechnology companies surveyed by the Spanish Bioindustry Association (ASEBIO) stated that COVID-19 had affected clinical research and development by delaying project times. In contrast, 9.6 percent answered that COVID-19 affected positively, with speeded-up objectives and new projects.